Recensa Therapeutics' Seed Round

Recensa Therapeutics raised a round of funding on June 13, 2017. Investors include Phase 1 Ventures.

Recensa Therapeutics screens for molecules that stimulate the body's anti-oxidant response against inflammation. Recensa is using this technology to develop topical therapies for the treatment of psor…

Articles about Recensa Therapeutics' Seed Round: